Skip to main content

Multiple Sclerosis Discovery Forum

Inspiring Connections

Utility Navigation

Feedback
Newsletter
RSS
Twitter

User Top Menu

Welcome, guest
Log In
Join
Why Join?

Search form

Search

About Us
- Overview
- Who We Are
- Contact
- Fan Mail
- How to Cite
News & Future Directions
Papers
Forums
- Discussions
- Webinars
Professional Resources
Research Resources
Click Here to Support MSDF

You are here

Most Viewed Papers

Progressive multiple sclerosis: The treatment gap.
Sleep Disorders and Multiple Sclerosis: A Clinical and Polysomnography Study.
Influence of pregnancy on neuromyelitis optica spectrum disorder.
Multiple sclerosis treatment: current best practice.
Simvastatin shows promise in treating progressive multiple sclerosis, study finds.
Incidence of multiple sclerosis in Northern Lisbon, Portugal: 1998¿2007.
Infectious causes of multiple sclerosis.
New Disease-Modifying Therapies and New Challenges for MS.
Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporter.
Effects of Panax ginseng in Neurodegenerative Diseases.
How Natalizumab Binds and Antagonizes α4 Integrins.
Modeling of cognitive impairment by disease duration in multiple sclerosis: a cross-sectional study.
Motor programme activating therapy influences adaptive brain functions in multiple sclerosis: clinical and MRI study.
Oligodendrocytes and the early multiple sclerosis lesion.
Inflammation-mediated memory dysfunction and effects of a ketogenic diet in a murine model of multiple sclerosis.
Dalfampridine Effects Beyond Walking Speed in Multiple Sclerosis.
Efficacy of idebenone for respiratory failure in a patient with Leigh syndrome: a long-term follow-up study.
Does glatiramer acetate provoke hepatitis in multiple sclerosis?
miRNA in multiple sclerosis: search for novel biomarkers.
Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor.
Bayer Receives FDA Approval for BETACONNECT - First and Only Electronic Autoinjector in Relapsing-Remitting Multiple Sclerosis (RRMS) Treatment
Genzyme receives Complete Response Letter from FDA on Lemtrada™ (alemtuzumab) application
MARGA: Multispectral Adaptive Region Growing Algorithm for brain extraction on axial MRI.
Innovation at RUSH
High-dose cyclophosphamide in multiple sclerosis patients undergoing autologous stem cell transplantation.

Pages

« first
‹ previous
…
122
123
124
125
126
127
128
129
130
…
next ›
last »

MSDF Footer

Copyright © 2014 MGH and ACP

Privacy
Terms of Use
How to Cite
FAQ/Help
Site Map
Support Us
Feedback
Image Credits

All site content, except where otherwise noted, is licensed under a Creative Commons BY license. Please let us know where and how you use MSDF material.

Content By

Software By